The feedback loop between domain experts and AI engineers is exactly what makes AI for science so exciting. The model gets better from the scientist, the scientist gets to explore more because of the model.
AI
-
AI Medical Breakthroughs Moving Beyond Human Knowledge
By
–
tu vois qu'il donne des réponses de bot. Non la vraiment y'a une avancé phénoménale et moi je le vois côté avancées en médecine, on commence a s'éloigner du "c'est un humain qui l'a déjà dit"
-
Subagents in Codex: Production Challenges and Value
By
–
i cannot tell you how valuable and impt subagents are in codex! last week i released a vibe-coded document editor, proof. the past few days have just been me fighting production bugs by copy-pasting log outputs and bug reports into new threads and then trying to manually
-
Replit Agent 4: Faster Planning, Design, and Development
By
–
Move faster with Agent 4
— Replit ⠕ (@Replit) 17 mars 2026
• Plan, design, and build at the same time
• Build multiple features in parallel
Try now at: https://t.co/aQCQXj8cbH pic.twitter.com/eN4G4aqdCCMove faster with Agent 4 • Plan, design, and build at the same time
• Build multiple features in parallel Try now at: http://
replit.com/agent4 -
AI Secret: Scale versus Proprietary Techniques
By
–
Is there a "secret sauce" driving the development of AI models?
— MIT CSAIL (@MIT_CSAIL) 17 mars 2026
FutureTech researchers at MIT CSAIL found that at the frontier, sheer scale drives LLM performance, but proprietary techniques & algorithmic advances matter more away from it: https://t.co/zi6jCN7twT pic.twitter.com/UpDdLG7c6YIs there a "secret sauce" driving the development of AI models? FutureTech researchers at MIT CSAIL found that at the frontier, sheer scale drives LLM performance, but proprietary techniques & algorithmic advances matter more away from it: bit.ly/4l76v2g [Translated from EN to English]
→ View original post on X — @mit_csail, 2026-03-17 16:00 UTC
-
AstraZeneca and Tempus AI Achieve 15% Survival Benefit with Contrastive Learning
By
–
AstraZeneca and Tempus AI used contrastive learning to find biomarkers that predict treatment response. Outcome: 15% survival benefit over traditional immuno-oncology trial designs. AI catching what human researchers couldn't. That's not incremental. #AI
→ View original post on X — @svenphilipsen, 2026-03-17 16:00 UTC
-
Am I Writing My Posts or Is AI Writing Them?
By
–
j'ai un gros doute de savoir si c'est moi qui écris mes posts, ou si c'est toi.
-
French Synthetic Data at Scale: Regional Variation Challenges
By
–
Super cool to see French-grounded synthetic data at this scale! As a French-Canadian, curious how the demographic distributions handle regional French variations 🙂 It's usually pretty bad especially voice generation haha.
-
AI weapons testing raises serious ethical concerns
By
–
les 7% sont en train d'être montés sur des roquettes pour tester l'impact de tirs sur l'humain.
-
Elsevier Recognized as Top Best Company for Women
By
–
Elsevier is proud to create a workplace where people can grow, contribute, and feel confident about the future. Comparably recognozes Elsevier as a Top Best Company for Women and Business Outlook.🌟
— Catherine Adenle (@CatherineAdenle) 17 mars 2026
🔗 Join us: https://t.co/HYx75Cnd90
📰 Read more: https://t.co/orQmFDqQRD… pic.twitter.com/JQMzZx5xSNElsevier is proud to create a workplace where people can grow, contribute, and feel confident about the future. Comparably recognozes Elsevier as a Top Best Company for Women and Business Outlook. Join us: http://
spkl.io/6046ALp6w Read more: http://
spkl.io/6048ALp6j